TRACE4AD

TRACE4AD is indicated for subjects at risk of Alzheimer's disease dementia on the recommendation of neurology specialists. Radiology specialists with neuroradiological expertise can use TRACE4D to support the reporting of brain MRI investigations in these subjects. Neurology specialists can use TRACE4AD as an aid to diagnosis and prognosis. TRACE4AD software provides the subject level of risk (low risk or high risk) of being affected by or progressing to Alzheimer's disease dementia within 24 months of the date of the TRACE4AD processed examination, i.e., the subject's brain MRI investigation, possibly in combination with a neuropsychological examination performed no earlier than and no later than one month from the brain MRI. However, it should be noted that DeepTrace Technologies S.R.L. considers TRACE4AD as a support to the neurologists in their diagnosis and prognosis, and as a support to the radiology specialists with neuroradiological expertise in their reporting of brain MRI investigations, who have the sole decision making responsibility.